These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 18060371)
1. Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases. Ciszak L; Pawlak E; Kosmaczewska A; Potoczek S; Frydecka I Arch Immunol Ther Exp (Warsz); 2007; 55(6):373-86. PubMed ID: 18060371 [TBL] [Abstract][Full Text] [Related]
2. Altered expression of the T cell receptor-CD3 complex in systemic lupus erythematosus. Takeuchi T; Tsuzaka K; Abe T Int Rev Immunol; 2004; 23(3-4):273-91. PubMed ID: 15204089 [TBL] [Abstract][Full Text] [Related]
3. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689 [TBL] [Abstract][Full Text] [Related]
4. [Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results]. Musiał K; Ciszak L; Kosmaczewska A; Szteblich A; Pawlak E; Zwolińska D; Frydecka I Przegl Lek; 2006; 63 Suppl 3():208-10. PubMed ID: 16898532 [TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus. Nambiar MP; Enyedy EJ; Fisher CU; Krishnan S; Warke VG; Gilliland WR; Oglesby RJ; Tsokos GC Arthritis Rheum; 2002 Jan; 46(1):163-74. PubMed ID: 11817588 [TBL] [Abstract][Full Text] [Related]
6. Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus. Nambiar MP; Juang YT; Krishnan S; Tsokos GC Int Rev Immunol; 2004; 23(3-4):245-63. PubMed ID: 15204087 [TBL] [Abstract][Full Text] [Related]
8. Altered signaling triggered by ligation of the TCR/CD3 receptor in T lymphocytes from patients with systemic lupus erythematosus: the road from anergy to autoimmunity. Blasini AM; Rodríguez MA Int Rev Immunol; 2004; 23(3-4):265-72. PubMed ID: 15204088 [TBL] [Abstract][Full Text] [Related]
9. Protooncogenes and autoimmunity. Rapoport M; Mor A; Bistritzer T; Ramot Y; Levi O; Slavin S; Wysenbeek A Isr J Med Sci; 1997 Apr; 33(4):262-6. PubMed ID: 9347876 [No Abstract] [Full Text] [Related]
11. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients. Fujii Y; Fujii K; Tanaka Y Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347 [TBL] [Abstract][Full Text] [Related]
12. Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system. Fülöp T; Larbi A; Dupuis G; Pawelec G Arthritis Res Ther; 2003; 5(6):290-302. PubMed ID: 14680505 [TBL] [Abstract][Full Text] [Related]
14. Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients. Taylor DD; Bender DP; Gerçel-Taylor C ; Stanson J; Whiteside TL Br J Cancer; 2001 Jun; 84(12):1624-9. PubMed ID: 11401315 [TBL] [Abstract][Full Text] [Related]
15. The short length of the extracellular domain of zeta is crucial for T cell antigen receptor function. Minguet S; Swamy M; Schamel WW Immunol Lett; 2008 Mar; 116(2):195-202. PubMed ID: 18207249 [TBL] [Abstract][Full Text] [Related]
16. Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients. Eleftheriadis T; Kartsios C; Yiannaki E; Kazila P; Antoniadi G; Liakopoulos V; Markala D Am J Nephrol; 2008; 28(1):152-7. PubMed ID: 17951997 [TBL] [Abstract][Full Text] [Related]
17. How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. Crispín JC; Kyttaris VC; Juang YT; Tsokos GC Trends Immunol; 2008 Mar; 29(3):110-5. PubMed ID: 18249583 [TBL] [Abstract][Full Text] [Related]
18. Alterations in signal transducing molecule CD3 zeta in patients with neoplastic diseases. Frydecka I; Kaczmarek P; Boćko D; Kosmaczewska A; Ciszak L Arch Immunol Ther Exp (Warsz); 1998; 46(6):355-9. PubMed ID: 9883314 [TBL] [Abstract][Full Text] [Related]